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Extracts obtained from 57 marine-derived fungal strains were analyzed by HPLC-PDA, TLC and 1H NMR. The analyses showed
that the growth conditions affected the chemical profile of crude extracts. Furthermore, the majority of fungal strains which produced
either bioactive of chemically distinctive crude extracts have been isolated from sediments or marine algae. The chemical investigation
of the antimycobacterial and cytotoxic crude extract obtained from two strains of the fungus Beauveria felina have yielded
cyclodepsipeptides related to destruxins. The present approach constitutes a valuable tool for the selection of fungal strains that
produce chemically interesting or biologically active secondary metabolites.
Keywords: marine-derived fungi; screening; Beauveria felina.
INTRODUCTION
Considering that the occurrence of fungi in the marine
environment was first reported late in the nineteenth century1-4 and
that the oceans cover more than 70% of the Earth’s surface, the
number of species of marine fungi which have been described is
surprisingly much smaller than terrestrial species. This is because
not only is marine mycology a recent science, but also because it
seems to be inherently more difficult to access artificial media and
growth conditions to isolate and to grow both new facultative and
new obligate marine fungi.5-9
Obligate marine fungi have been defined either as capable of
producing successive generations by sexual and asexual means in
natural oceanic waters and oceans diluted by freshwater or on
intertidal substrates5 or as those which grow and sporulate
exclusively in a marine environment. On the other hand, facultative
marine fungi are aquatic and terrestrial microorganisms that are
able to grow in marine environments.10 Until 1991, only 321 species
of obligate marine fungi had been described,11 the majority
belonging to the class Ascomycete, which are found in shallow
waters, frequently associated with marine algae, decomposing
wood,7 crabs, fishes and sponges.11-13 Facultative marine fungi have
been explored to a lesser extent, and only 56 species have been
described until 1999.14
Recently, marine-derived fungi have been recognized as one of
the last barely tapped sources for new biologically active secondary
metabolites,2,6,8,11-13,15 including antitumor, antibacterial, antiviral,
antifungal, anti-inflammatory and enzyme inhibitor compounds.16
This is probably because marine fungi have been explored to a
much lesser extent than their terrestrial counterparts, which have
been known for a long time as a very important source of biologically
active and economically important natural products, such as those
for use in treatment of human diseases as well as several others in
biotechnological applications.17-19
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We have recently started the first research program in Brazil
towards the search for new biologically active secondary metabolites
from marine bacteria and fungi.20,21 In order to establish a protocol
to select strains capable of producing bioactive secondary
metabolites, we envisaged a multi-screening approach using both
biological and chemical methods for prioritizing extracts obtained
from marine-derived fungi. The subsequent investigation of crude
extracts obtained from two strains of Beauveria felina led to the
isolation of a series of cyclodepsipeptides related to destruxins.
EXPERIMENTAL
Marine fungi strains
Fifty seven strains of marine-derived fungi were isolated from
sediments, algae (Sargassum cymosum, Padina sp., Caulerpa sp.
and an unidentified species of marine algae), one sponge (Tedania
ignis) and one sea anemone (Anemonia sargassensis) (see Table
1), obtained at two locations: Cabelo Gordo de Fora beach, São
Sebastião, São Paulo state north coastline (S 23o 49' 656'’; W 45o
25' 351'’); and Balneário beach, Peruíbe, São Paulo state south
coastline (S 24º 19' 12"; W 46º 59' 54"). Samples were processed
as follows: Peruíbe sediment samples were collected with a
sterilized spatula and preserved in sterilized culture tubes (12 mL)
containing 10 mL of sterile sea water. After collection, the samples
were maintained at 4 oC for transportation to laboratory. Marine
invertebrate and algae samples were collected at São Sebastião with
sterilized tweezers, while sediment samples were collected by
immersion of closed sterilized tubes opening them underwater and
the samples were immediately collected. Sediment samples were
diluted (1:1,000, 1:10,000 and 1:100,000) in sterilized sea water,
followed by 200 μL inoculation in Petri dishes containing MF
culture medium (2% glucose, 1% soluble starch, 2% soytone, 0.5%
peptone, 0.3% meat extract, 0.5% yeast extract, rifampicin 0.03%,
agar 1.5% in 100 mL sterilized sea water). Invertebrate and algae
samples were also preserved in sterilized sea water. For fungal
isolation, the biological samples (sponge, sea-anemone and algae)
were strongly stirred with a vortex for one minute, and subsequently
200 μL of each sample was inoculated in Petri dishes with MF
medium. The inoculated samples were allowed to grow for 7 days
at 25 oC. Fungal isolates were obtained by exhaustive purification
in Petri dishes and the purified strains were preserved in silica-gel
in sealed eppendorfs22 at 4 oC.
Strain growth in artificial medium
Each fungal strain was placed in two Pyrex culture tubes (12
mL), containing 5 mL of MF agar and incubated at 25 oC. After 7
days, a 0.85% NaCl solution was added to each tube. Mycelia were
scraped from the surface and each strain was transferred to a 500
mL Erlenmeyer flask containing 250 mL of MF broth. Each of the
57 isolates was grown in shaker culture and still culture. After
fermentation, 250 mL of methylethylketone (butanone) was added
to each of the 114 marine fungi samples that were cultured in MF
medium.
Chemical analysis of crude extracts
Each sample obtained from the MF culture (liquid medium +
mycelia + butanone mixture) was blended in a Waring-blender, and
left overnight before filtering through a Whatman #1 filter paper.
The remaining solid residue was discarded. The filtrate was
transferred to a separatory funnel, the organic layer collected,
evaporated in vacuo, transferred to a small vial with MeOH, and
evaporated to dryness in a Speedvac system (Savant) and weighed.
Aliquots of each crude extract were diluted with MeOH and analyzed
by high performance liquid chromatography with a photodiode array
detector (HPLC-PDA). Small aliquots of each crude extract were
also prepared for thin layer chromatography (TLC) and for 1H nucle-
ar magnetic resonance (1H NMR) analyses. HPLC-PDA analyses
were performed with a Waters 717 autosampler, Waters 600 pump,
Waters 2996 photodiode array detector monitored by Waters
Millenium 32. The column used was a Waters μBondapak C18 reversed
phase silica gel, 300 x 7.8 mm. Eluent: 100% H2O for 1 min, then a
#4 convex gradient curve for 25 min to 100% MeOH, and held at
100% MeOH for 5 min at 1 mL/min.
TLC analyses were performed with Aldrich precoated silica-
gel plates with fluorescent UV indicator (254 nm). Each sample
was applied in six separate plates. Three plates were eluted with a
mixture of 1:1 hexanes-ethyl acetate (solvent # 1), and 3 plates
were eluted with 9:1 CH2Cl2-MeOH (solvent # 2). After elution, all
chromatographic plates were inspected under ultraviolet light (λ
max
254 nm). One of the plates eluted with solvent #1 was sprayed with
a solution of phosphomolybdic acid (5% in EtOH), one with
Dragendorff reagent and the last one with ninhydrin (5% in EtOH).
Plates eluted with solvent #2 were subjected to the same procedure.
1H NMR analyses were performed with a Bruker AC200 4.7
Tesla instrument, operating at 200.1 MHz (1H). Approximately 10
mg of each sample was diluted in deuterated dimethylsulfoxide
with TMS as an internal standard.
Biological assays
Antibacterial activity
Bacterial samples were prepared according to Nascimento et
al..23 Bacterial strains included: Pseudomonas aeruginosa (ATCC
27583), Escherichia coli (ATCC 259222), Staphylococcus aureus
(ATCC 25923), Enterococcus faecalis (ATCC 29212), Salmomella
cholaraesusis (ATCC 10708), and the yeast Candida albicans ATCC
10231. The following resistant strains, isolated at the Piracicaba
city hospital, were also subjected to the antibacterial assay: E. coli
#9, E. cloacae, S. aureus #8, S. aureus #18, S. aureus #68, S. aureus
#115 and S. aureus #134. Aliquots of 5 mg of each fungal crude
extract were subjected to the antibacterial bioassay following our
previously reported procedure.24
Antimycobacterial activity against Mycobacterium tuberculosis
H37Rv
The antimycobacterial activity of the crude extracts was
determined according to standard reported procedures.3,25
 Inhibition of Leishmania tarentolae adenine phosphoribosyl-
transferase (L-APRT)
The inhibition of L-APRT was performed following a modified
protocol described by Tuttle and Krenitsky.26
Cytotoxicity assays
HL-60 (leukemia), B16 (melanoma) and HCT8 (colon) cancer
cell lines were obtained from Children’s Mercy Hospital, Kansas
City, MO. The microtiter assay for cytotoxicity was performed using
the sulforhodamine B (SRB) method27 according to our previously
described procedure.24
Identification of fungal strains
Preliminary identification of all strains was made by macro-
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and microscopic analysis. Beauveria felina strains AcSS8 and
AcSS13 were identified by molecular and conventional methods,
including DNA isolation, ITS amplification and subsequent
sequencing. DNA were isolated following the method described
by Raeder and Broda.4 The ITS1/ITS2 regions were amplified with
the primers ITS1 (5´-CCGTAGGTGAACCTGCGG-3’) and ITS4
(5’-TCCTCCGCTTATTGATATGC-3’). Polymerase chain reaction
DNA amplifications were performed in final reactions mixtures
(25 μL) containing 5-25 ng genomic DNA, 0.4 μM of each primer,
0.2 μM dNTPs (GE Healthcare), 1.5μM MgCl2 (Invitrogen), 2.0 U
Taq polymerase (Invitrogen) and 1.0X reaction buffer (Invitrogen).
Amplification reactions were performed in a PCR Sprint (Hybaid)
with the following cycling conditions: initial denaturation for 5
min at 94 ºC followed by 30 cycles of 30 s at 94 ºC, 30 s at 55 ºC
and 1 min at 72 ºC with a final extension for 10 min at 72 ºC and
cooling to 4 ºC. Amplified products were purified, quantified and
subjected to sequencing using the DYEnamic ET Dye Terminator
Cycle Sequencing Kit for an automated MegaBace sequencer (GE
Healthcare). The set of primers used for sequencing were ITS1 and
ITS4.
Sequences were compared with ITS1/ITS2 sequence data from
strains available in the public databases Genbank (http://
www.ncbi.nem.nih.gov) by using the BLAST N sequence match
routines. The sequences were aligned using the CLUSTAL X
program and phylogenetic and molecular evolutionary analyses were
conducted using MEGA version 2.0.28 The Kimura two-parameter
model29 was used to estimate evolutionary distance. The
phylogenetic reconstruction was done using the neighbor-joining
(NJ) algorithm, with bootstrap values calculated from 1,000
replicate runs, using the software routines included in the MEGA
software.
After identificaton, Beauveria felina strains AcSS8 and AcSS13
were deposited at the Brazilian Collection of Microorganisms from
Environment and Industry (CBMAI, Campinas, SP) under the
numbers CBMAI 738 and CBMAI 739, respectively.
RESULTS
Among the 57 fungal strains isolated from the marine
environment, 28 have been identified by morphological and
biochemical analyses and are listed in Table 1S (Supplementary
Material). We have been unable to identify twenty-nine strains of
marine-derived fungi because these species did not sporulate in
laboratory conditions. The majority of the identified strains belong
to genera Penicillium (8 strains), Verticillium (5 strains), Aspergillus
(2 strains) and Phoma (2 strains). Among the 57 strains of marine-
derived fungi obtained, 28 have been isolated from sediments and
21 from the marine algae Padina sp., Caulerpa sp., Sargassum
cymosum and one unidentified alga species. One fungal strain was
isolated from the sponge Tedania ignis and 3 from the sea-anemone
Anemonia sargassensis (Table 1S). All marine-derived fungi studied
in the present work were grown both in saline and salt-free media,
and results showed that 14 strains grew exclusively in saline medium
(Table 1S).
All fungal strains were grown in MF medium in two different
conditions: dynamic (shaking at 200 rpm, 7 days) and still mode (30
days). Crude extracts were obtained from each strain grown in both
conditions. Crude extracts obtained from strains which were grown
dynamically presented less mass quantity than crude extracts obtained
from the medium of strains which were grown under still conditions.
Not only the quantity of the organic crude extract obtained from
each strain was different when it was grown in the two conditions,
but also the chemical composition was different, as observed by
HPLC-PDA, TLC and 1H NMR analyses, as well as by the bioassays
results (Tables 1S and 2S, Supplementary Material).
TLC analyses of all 114 crude extracts indicated that 12 extracts
presented nitrogen-bearing compounds (revealed by Dragendorff
reagent, Table 1S). These included Phoma sp. (S2SS4), Beauveria
felina (AcSS13), Rhinocladiella sp. 2 (AdSSP15), Pestalotiopsis
sp. (SP51), and the unidentified strains S3SS5, AaSS17, S1SS23,
S1SS25, AaSS27, S2SS32, S1SS34, and SP56. All crude extracts
were also analyzed by HPLC-PDA, and the results showed that
only twenty presented a distinctive chromatographic pattern (Table
1S), with peaks showing UV absorptions with λ
max
 above 250 nm,
characteristic of conjugated systems. Among these, 11 were
obtained from fungi grown under still conditions and 9 under
shaking; 12 were obtained from fungi isolated from marine
sediments, 6 from marine algae, 1 from the sea anemone A.
sargassensis and 1 from the sponge T. ignis. Crude extracts obtained
from Penicillium sp. 5 (ESS41) isolated from T. ignis, as well as
from Penicillium sp. (AcSS53), and Penicillium sp. 8 (AcSS54)
isolated from the alga Caulerpa sp. presented the richest chemical
profiles, indicated by the number of peaks in the chromatograms
with distinctive UV absorptions. The twenty crude extracts selected
by HPLC-PDA were subjected to 1H NMR analysis. The 1H NMR
spectra showed several signals indicating the presence of aromatic
and/or unsaturated groups, as well as oxygen- and/or nitrogen-
containing functional groups.
The 114 crude extracts from derived-marine-fungi were also
submitted to four bioassays: antibacterial activity against common
and resistant strains of human pathogenic bacteria and against
Mycobacterium tuberculosis H37Rv; antifungal activity against
Candida albicans; inhibition of the enzyme adenine phosphori-
bosyl transferase of Leishmania tarentolae (L-APRT); as well as
cytotoxic activity against human cancer cell lines (Table 2S). None
of the crude extracts displayed inhibitory activity against L-APRT.
Eleven of the crude extracts displayed antimycobacterial activity
against M. tuberculosis H37Rv. Twenty three extracts of the marine-
derived fungi displayed antibacterial activity: one against P.
aeruginosa, 1 against antibiotic-resistant E. coli, 1 against
antibiotic-sensitive E. coli, 10 against S. aureus of which 1 (Phoma
sp., S2SS24) exhibited disc inhibition zones higher than 20 mm,
10 extracts displayed activity against different strains of antibacterial
resistant S. aureus, 1 against E. faecalis, 1 against S. choleraesusis
and 1 against antibacterial resistant strain of E. cloacae. In addition,
3 marine-derived fungal strains yielded crude extracts with strong
antifungal activity against C. albicans: Verticillium sp. 5 (AcSS52),
Penicillium sp. (AcSS53) and SP56. Finally, 14 marine-derived
fungal strains yielded crude extracts which displayed considerable
anti-proliferative activity against 1 or more of the tumor cell lines
(Table 2S), 6 of them with potent cytotoxic activity: Beauveria
felina (AcSS8 and AcSS13), Penicillium sp. 2 (CSS19), strain
S2SS24, Verticillium sp. 1 (S1SS30) and strain S1SS31 (Table 2S).
The results of chemical (HPLC-PDA and TLC) and bioassay
(antimycobacterial, antibacterial, anti-fungal and cytotoxic)
screenings were all combined in order to obtain additional
information to reveal strains that produced bioactive secondary
metabolites (Tables 3S and 4S). Results obtained from the HPLC-
PDA analyses showed that the growth mode (shaken or still) had
only partial influence on the chemical profile of the crude extracts,
since the number of crude extracts with distinctive chromatograms/
UV absorptions was practically equal for fungi grown either in
still or dynamic conditions. The same observation was true for
extracts which presented nitrogen-bearing compounds and
antibacterial activity. However, only crude extracts obtained from
fungi which were grown in still mode displayed antifungal activity
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against C. albicans and cytotoxic activity, with one exception. The
majority of marine-derived fungal strains which yielded crude
extracts with either an interesting chemical profile, nitrogen-bearing
compounds, antibacterial, antifungal and cytotoxic activities were
strains isolated from either sediments or marine algae (Table 3S).
We subsequently selected the crude extracts of fungal strains
AcSS8 and AcSS13 for chemical investigation, since the crude extract
of AcSS8 presented a single peak with distinctive UV absorption
above λ
max
 280 nm, the crude extract of AcSS13 displayed positive
Dragendorff reaction and both extracts presented cytotoxicity and
antimycobacterial activities. Data derived from taxonomic analyses
showed that these two strains belong to the same species and were
identified by conventional and molecular taxonomy as Beauveria
felina. Both extracts were obtained in sufficient quantity for chemical
fractionation by silica-gel chromatography followed by HPLC
purification. The crude extract obtained from AcSS-8 strain yielded
eight cyclodepsi-peptides (1 – 8) related to destruxins.30,31 All
compounds were identified by analysis of LC-MS, 1H NMR, 13C
NMR, COSY 1H-1H, HSQC, HMBC, TOCSY, high-resolution mass
spectrometry and comparison with literature data.30
DISCUSSION
Marine-derived fungi are considered a remarkable source of
biologically active natural products with new chemical struc-
tures.2,6,12,13 Therefore, it is of interest to develop different approaches
for the discovery of marine-derived fungal species that produce
biologically active secondary metabolites.
In the present investigation, 57 marine-derived fungi strains
have been isolated from sediments, algae and invertebrates (Table
1S). Fungal samples obtained from sediments or algae yielded crude
extracts with the richest chemical profile, as indicated by both
chemical and biological screenings. These fungi are likely to
produce bioactive secondary metabolites, corroborating the results
presented in the literature.6,12-14
The isolation of only 4 fungal strains from marine invertebrates
during the present investigation may be a reflection that fungi are
not usually present in sponge tissues.12 However, Höller et al.13
have been able to isolate more than 600 marine fungi strains from
tissues of marine sponges, Pivkin et al.14 isolated 38 marine fungi
strains from marine invertebrates, and Bernan et al.11 isolated 78
fungi strains from marine invertebrates. Consequently, it seems
reasonable to suppose that isolation of fungal strains from different
marine sources depends largely on the isolation and growth
procedures.
Although natural products isolated from marine-derived fungi
have been shown to present quite diverse chemotypes, only a few
of them were isolated from obligate marine strains.16 This may be
a direct consequence of methods used for strain isolation, which in
many instances are not adequate for the isolation or growth of
obligate marine fungal strains.6,12 Although in the past Kohlmeyer
and Kohlmeyer10 defined marine fungi as those species able to grow
and sporulate exclusively in the marine environment, it has recently
been suggested that this feature seems to be growth restrictive even
for obligate marine strains.12 On the other hand, facultative marine-
derived strains such as Aspergillus, Penicillium, Verticillium and
Phoma present a high degree of salinity tolerance and, therefore,
are frequently isolated12 and produce bioactive extracts and
compounds.6,11,13,14 Since the structural novelty of natural products
isolated from marine-derived fungi increases with species
diversification, it is also of interest to employ different methods
for isolation and growth of obligate marine or taxonomically rare
fungal strains.6,7
Results from growth conditions showed that 14 strains grew
exclusively in saline media (Table 1S), suggesting that these may
belong to the group of obligate marine fungi. However, additional
experiments on these strains must be performed, including
taxonomic identification, in order to confirm a true origin.
We also observed that fungal strains grown with shaking yielded
less quantity of crude extract than fungi grown under still conditions.
This may be a consequence of the longer period of growth (30
days) under still conditions. However, less exposure to aerobic
conditions seems to favour the production of secondary metabolites
by marine fungi under still conditions. Not only the quantity of the
organic crude extract obtained from each fungal species was
different when the same strain was grown in the two conditions,
but also the chemical composition was different, as observed by
HPLC-PDA, TLC and 1H NMR analyses, as well as by the bioassays
results (Tables 1S and 2S). Therefore, marine-derived fungi appear
to be highly sensitive to changes in growth conditions.6,7,13 Therefore,
it would be of interest to explore variation in medium composition
and growth conditions of fungi strains which appear to produce
secondary metabolites in order to enhance the production of natu-
ral products both in quantity and variety. According to Bugni and
Ireland,6 fungal metabolite production may be enhanced in higher
ionic concentrations, such as those found in ASW (artificial
seawater).
None of the crude extracts displayed inhibitory activity against
L-APRT. This result may be indicative of the bioassay specificity
since this is an enzyme-based assay that requires much more specific
active-site binding inhibitors.
In crossing the results obtained from this multi-screening, we
observed some interesting features for crude extracts, which
presented simultaneous chemically and biologically positive results.
Marine fungal strains grown under still conditions seem to produce
bioactive secondary metabolites more frequently, as shown in Table
4S (Supplementary Material). For example, 7 crude extracts
obtained from fungi grown under still conditions displayed both
antibacterial and cytotoxic activities. The majority of strains which
yielded crude extracts that presented metabolites detected in two
or three chemical and/or biological analyses simultaneously were
isolated from either sediments or marine algae. We also observed
that only a few fungal strains yielded crude extracts which presented
positive results in two simultaneous screening criteria, and even a
smaller number with positive results in three simultaneous screening
criteria (Table 4S). Such features are of special interest for the
selection of marine-derived fungal strains that produce chemically
interesting and biologically active natural products.
Based on their cytotoxic and antimycobacterial activities and
chemical profile, crude extracts obtained from Beauveria felina
strains AcSS8 and AcSS13 were selected for a chemical
investigation. We have been able to isolate eight cyclodepsipeptides:
the new pseudodestruxin C (1) and β-Me-Pro destruxin E
chlorohydrin (2),30 along with the known [Ph3, N-Me-Val5] destruxin
B (3), destruxin E chlorohydrin (4), roseotoxin B (5), roseocardin
(6), isariin (7) and isariin B (8).30,31 Destruxins are a well known
class of cyclic depsipeptides31 that present an array of biological
activities such as insecticidal, cytotoxic, antiviral, immuno-
depressant and phytotoxic. This is the first report of destruxin
derivatives from a marine-derived fungus associated with a marine
alga (Caulerpa sp.). The majority of these peptides have been
isolated from Metarrhizium anisopliae.31 The isolation of the
cyclodepsipeptides 1 – 8 from two strains of B. felina isolated from
the alga Caulerpa sp. constitute a validity for the multi-screening
herein reported. The choice of B. felina crude extracts was based
on three screening criteria: bioactivity, positive response to the
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Dragendorff reagent and distinctive UV absorption of a single peak
in the HPLC-PDA analysis.
In conclusion, the present study demonstrated that a multi-
screening approach, including both chemical and bioassay analyses
of crude extracts, is a helpful tool for the selection of marine-derived
fungal strains that present an active secondary metabolism, suitable
for the production of biologically active natural products, as
demonstrated by the isolation of biologically active cyclic
depsipeptides related to destruxins.
Since some of the marine-derived fungi isolated and analyzed
herein produced antimycobacterial, antibacterial, antinfungal, and/
or antitumor extracts, these strains can be considered as attractive
for further studies on the isolation and identification of bioactive
compounds, as well as for additional taxonomic analyses involving
a polyphasic approach in order to assign specific species
identification.
SUPPLEMENTARY MATERIAL
Tables 1S, 2S, 3S and 4S. This material is available at http://
www.quimicanova.sbq.org.br, in PDF file.
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Table 1S. Identification*, origin and growth media of the 57 strains of marine fungi, as well as the growth mode of marine-derived fungal
strains which yielded crude extracts with a distinctive chemical profile analyzed by HPLC-PDA and TLC
Fungi strain Origin MF Culture Growth HPLC-PDA TLC
medium mode distinctive (Dragendorff)
saline salt-free (# of peaks)
Unidentified fungus  S4SS1 Sediment  +  -
Hansfordia ovalispora  S4SS2 Sediment  +  + D  +   (1)  -
Unidentified fungus AbSS3 Padina sp.  +  -
Phoma sp. 1 S2SS4 Sediment  +  + D  +   (1)  +
Unidentified fungus S3SS5 Sediment  +  - D  +   (2)  +
Unidentified fungus S4SS6 Sediment  +  - D  +   (1)  -
Spadicoides sp. 1 S4SS7 Sediment  +  - D  +   (1)  -
Beauveria felina AcSS8 Caulerpa sp.  +  + D  +   (1)  -
Unidentified fungus AcSS9 Caulerpa sp.  +  + D  +   (1)  -
Unidentified fungus AcSS10 Caulerpa sp.  +  +
Unidentified fungus S4SS11 Sediment  +  +
Rhinocladiella sp. AcSS12 Caulerpa sp.  +  - S  +   (1)  -
Beauveria felina AcSS13 Caulerpa sp.  +  + D  -  +
Phoma sp. 2  AcSS14 Caulerpa sp.  +  -
Rhinocladiella sp. 2 Ad(SS)P15 Unidentified algae  +  - D  -  +
Penicillium sp. 1 S2SS16 Sediment  +  + S  +   (1)  -
Unidentified fungus AaSS17 Sargassum cymosum  +  + S  -  +
Unidentified fungus CSS18 Anemonia sargassensis  +  +
Penicillium sp. 2  CSS19 Anemonia sargassensis  +  + S  +   (1)  -
Unidentified fungus S2SS20 Sediment  +  -
Penicillium sp. 3  S1SS21 Sediment  +  +
Spadicoides sp. AbSS22 Padina sp.  +  +
Unidentified fungus S1SS23 Sediment  +  + D  -  +
Unidentified fungus S2SS24 Sediment  +  +
Quim. Novade Vita-Marques et al.S2
Table 1S.
Fungi strain Origin MF Culture Growth HPLC-PDA TLC
medium mode distinctive (Dragendorff)
saline salt-free (# of peaks)
Unidentified fungus S1SS25 Sediment  +  + S  -  +
Curvularia borreriae RP26 Rock  +  +
Unidentified fungus AaSS27 Sargassum cymosum  +  + S  -  +
Unidentified fungus S1SS28 Sediment  +  -
Penicillium sp. 4 AbSS29 Padina sp.  +  +
Penicillium sp. 1 S1SS30 Sediment  +  +
Unidentified fungus S1SS31 Sediment  +  + D  +   (1)  -
Unidentified fungus S3SS32 Sediment  +  + S  -  +
Unidentified fungus S2SS33 Sediment  +  +
Unidentified fungus S1SS34 Sediment  +  + S  -  +
Unidentified fungus AaSS35 Sargassum cymosum  +  -
Verticillium sp. 2 AaSS36 Sargassum cymosum  +  +
Unidentified fungus CSS37 Anemonia sargassensis  +  +
Verticillium sp. 3 S3SS38 Sediment  +  + S  +   (2)  -
Verticillium sp. 4 SP39 Sediment  +  +
Spadicoides sp. 2 AbSS40 Padina sp.  +  + S  +   (2)  -
Penicillium sp. 5 ESS41 Tedania ignis  +  + S  +   (4)  -
Penicillium sp. 6  AbSS42 Padina sp.  +  +
Aspergillus sp. 1 SP43 Sediment  +  -
Aspergillus sp. 2 SP44 Sediment  +  +
Penicillium sp. 7 RP45 Rock  +  +
Unidentified fungus AbSS46 Padina sp.  +  +
Unidentified fungus SP47 Sediment  +  + S  +   (2)  -
Unideitnfied fungus RP48 Rock  +  -
Unidentified fungus RP49 Rock  +  +
Unidentified fungus SP50 Sediment  +  + S  +   (1)  -
Unidentified fungus SP50 Sediment  +  + D  +   (1)  -
Pestalotiopsis sp. 1 SP51 Sediment  +  + S  +   (2)  +
Verticillium sp. 5 AcSS52 Caulerpa sp.  +  +
Penicillium sp. AcSS53 Caulerpa sp.  +  + S  +   (4)  -
Penicillium sp. 8  AcSS54 Caulerpa sp.  +  + S  +   (3)  -
Pestalotiopsis sp. 2 SP55 Sediment  +  -
Unidentified fungus SP56 Sediment  +  + S  -  +
Unidentified fungus AaSS57 Sargassum cymosum  +  +
*Alpha-numerical codes refer to the authors fungal sample repository, where voucher samples of all fungal strains have been deposited; D:
growth in dynamic mode with shaking at 200 rpm ; S: growth in still mode.
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Table 2S. Antimycobacterial, antibiotic, antifungal and cytotoxic activities of crude extracts obtained from marine fungi strains
FUNGI GROWTH MICROORGANISMS cell lines
STRAIN MODE
1 2 3 4 5 6 7 8 9 10 11 12 13 A B C
S4SS2 S - - - - - + - - - - - - - - - -
S2SS4 S +++ - - - - - - - - - - - - - - -
S3SS5 D - - - - + - - - - - - - - - - -
S - - - - - - - - - - - - - - - -
S4SS6 D + - - - - - - - - - - - - - - -
AcSS8 D - + - - - - - - - - - - - - - -
S ++ - - - - - - - - - - - - ++ +++ ++
AcSS9 S - - - - + - - - - - - - - - - -
AcSS12 S - - - - - - - - - - - - - - - +
AcSS13 D - - - - - - - - - - - - - - - +
S ++ - - - - - - - - - - - - + +++ ++
AdP15 S - - - - - - - - - - - - - + ++ ++
S2SS16 S - - - - - - - - - - - ++ - - + ++
CSS19 D - - - - - - - + - - - - - - - -
S - - - - - - - - - - - - - + + +++
AbSS22 D + - - - - - - - + ++ - - - - - -
S1SS23 D - - - - + - - - - - - - - - - -
S2SS24 D - - - - +++ - - - - - - - - - - -
S - - - - - - - - - - - - - ++ ++ ++
S1SS25 S ++ - - - - - - - - - - - - - ++ +
RP26 D - - - - - - - - - - - + - - - -
S1SS28 S - - - - - - - - - - - - - - + -
AbSS29 D ++ - - - - - - - - - - - - - - -
S1SS30 S +++ - - - - - - - - - - - - + +++ +++
S1SS31 S - - - - - - - - - - - - - + ++ +++
S3SS32 S - - - - - - + - + - - - - - + +
S2SS33 S ++ - - - - - - - - - - - - - + -
AaSS35 D - - - - + - - - - - - - - - - -
S3SS38 S - - - - - - - - - - - - - - + +
SP43 D - - - - - - - - - - + - - - - -
SP44 D - - - - - - - + + - - - - - - -
RP45 D - - - - - + - - - - - + - - - -
AbSS46 D - - - - + - - - - - - - - - - -
SP47 S - - - - + - - - - - - - - - - -
RP49 D - - - - + - - - + - - - - - - -
AcSS52 S - - - - + - - - - - - - +++ - - -
AcSS53 S - - - - + - - - - - - - +++ - - -
AcSS54 D - - + - - - - - - - - - - - - -
SP55 D +++ - - - - - - - - - - - - - - -
SP56 S +++ - - + - - - - - - - - +++ - - +
AaSS57 D - - - - - - - + - - - - - - - -
S - - - - - - - - - - - - - - + -
Growth mode: D: dynamic (stirring at 200 rpm); S: still. Microorganism strains: 1: M. tuberculosis; 2: P. aeruginosa ATCC 27583; 3: E.
coli (antibiotic resistant); 4: E. coli ATCC 25922; 5: S. aureus ATCC 25923; 6: S. aureus resistant strain #8; 7: S. aureus resistant strain #18;
8: S. aureus resistant strain #115; 9: S. aureus resistant strain #134; 10: E. faecalis ATCC 29212; 11: S. choleraesuis ATCC 10708; 12: E.
cloacae resistant strain #19; 13: C. albicans ATCC 10231; Tumor cell lines A: MCF-7 (breast); B: HCT-8 (colon); C: B16 (murine
melanoma). Antibacterial activity level: + inhibition zone >10 mm and < 14 mm; ++ inhibition zone > 15 mm and < 20 mm; +++ inhibition
zone > 20 mm, except for M. tuberculosis. Antimycobacterial activity level against M. tuberculosis: +++ inhibition at 31.25 μg/mL; ++
inhibition at 62.5 μg/mL; + inhibition at 125 μg/mL. Antiproliferative activity level: + inhibition up to 50% of cancer cell growth; ++
inhibition between 50 and 75% of cancer cell growth; +++ inhibition larger than 75% of cell growth. – Not active.
Quim. Novade Vita-Marques et al.S4
Table 3S. Number of crude extracts obtained from marine fungal strains that displayed distinctive chemical profiles and biological activites
Fungi strains PDA-HPLC TLC Antibacterial Antifungal Cytotoxic
Growth mode still 11 7 14 3 15
dynamic 9 5 18 0 1
Origin sediments 12 8 19 1 9
algae 6 4 12 2 5
sponge 1 0 0 0 0
cnidarian 1 0 1 0 1
Table 4S. Number of crude extracts obtained from marine-derived fungi that presented simultaneously two or three chemical profile and/
or biological activities
Biological (1) (1) (1) (1) (2) (2) (2) (3) (3) (1) (2) (2) (3)
activities + (2) + (3) + (4) + (5) + (3) + (4) + (5) + (4) + (5) + (2) + (3) + (4) + (4)
+ (3) + (4) + (5) + (5)
Fungi still 1 3 1 3 3 1 3 3 7 0 1 1 1
Growth mode dynamic 2 3 0 0 1 0 1 0 0 1 0 0 0
Fungi sediments 2 4 0 1 4 1 3 1 5 1 1 1 1
Origin algae 0 2 1 1 0 0 1 2 2 0 0 0 0
sponge 0 0 0 0 0 0 0 0 0 0 0 0 0
cnidarian 0 0 0 1 0 0 0 0 0 0 0 0 0
Legend: (1): distinctive HPLC-PDA chemical profile (chromatograms with peaks which displayed UV absorptions with λ
max
 above 250
nm); (2) Alkaloids present (Dragendorff positive in TLC analysis); (3) Antibacterial positive; (4) Antifungal positive; (5) Cytotoxic posi-
tive.
